证券代码：300555 证券简称：ST路通 公告编号：2025-055 无锡路通视信网络股份有限公司 关于收到江苏证监局行政监管措施决定书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一是公章管理内部控制存在缺陷。公司公章使用内部控制存在明显缺陷，与 公司《2022 年度内部控制自我评价报告》中披露情况不符。《2022 年度内部控 制自我评价报告》信息披露不准确，违反了《上市公司信息披露管理办法》（证 监会令第 182 号）（以下简称《信披办法》）第三条第一款规定，公司时任董事 长林竹、时任监事会主席黄茂钦对上述行为负有主要责任。 二是公司未及时披露重大诉讼及账户冻结情况。公司在 2025 年 2 月 10 日收 到诉讼通知且银行账户被冻结后，未及时披露该信息，迟至 2025 年 3 月 12 日才 予披露，违反了《信披办法》第三条第一款、第二十二条第二款的规定。公司董 事长、时任总经理、时任代行董秘职责的邱京卫、时任代行董秘职责的付新悦等 对上述行为负有主要责任。 根据《信披办法》第五十二条规定，我局决定对你们采取出具警示函的行政 监管措施，并记入 ...

Group 1 - Vanke A's largest shareholder, Shenzhen Metro Group, plans to provide a loan of up to 3 billion yuan to the company for repaying bond principal and interest [1] - The loan term will not exceed 36 months, with an interest rate based on the 1-year Loan Prime Rate (LPR) minus 66 basis points, currently at 2.34% [1] Group 2 - Gongchuang Turf's stock price has increased for five consecutive trading days, with a total rise of 58.00%, significantly deviating from the Shanghai Composite Index [2] - The company generates 88.62% of its revenue from overseas, and is closely monitoring the uncertain U.S. tariff policies [2] - In 2024, the revenue from leisure grass and sports grass is projected to be 2.052 billion yuan and 594 million yuan, accounting for 69.93% and 20.25% of main business revenue, respectively [2] Group 3 - Jinling Sports announced that some venues in the Scottish Premier League used the company's football competition equipment, but the impact on the company's performance is currently minimal [3] Group 4 - Filinger's stock has seen significant increases, but the completion of the control transfer remains uncertain, pending regulatory approval [4] - The company has not disclosed any major changes in its fundamentals [4] Group 5 - Huamai Technology's business is currently focused on communication infrastructure, including optical communication products and wireless communication network construction products [5] Group 6 - Longbai Group plans to repurchase shares worth 500 million to 1 billion yuan for employee stock ownership plans, with a maximum repurchase price of 24.82 yuan per share [6] Group 7 - Stone Technology intends to issue H-shares and list on the Hong Kong Stock Exchange, pending shareholder approval and regulatory approvals [7] Group 8 - ST Tianyu and its actual controller are under investigation by the CSRC for suspected information disclosure violations, but this will not significantly impact the company's operations [8][9] Group 9 - Honghui Fruits' controlling shareholder is planning a share transfer that may lead to a change in control, resulting in a temporary suspension of trading [10] Group 10 - Cambridge Technology's major shareholders plan to reduce their holdings by up to 8.0413 million shares, representing 3.00% of the total shares [11] Group 11 - Jialin Jie announced that its controlling shareholder's associates received administrative penalties unrelated to the company, which will not affect its daily operations [12] Group 12 - GAC Group reported a May automobile sales figure of 117,698 units, a year-on-year decline of 24.80% [13] - Shennong Group sold 232,800 pigs in May, generating revenue of 413 million yuan [14] - Dabeinong sold 727,600 pigs in May, with revenue of 1.248 billion yuan [15] - Tangrenshen's pig sales increased by 47.69% year-on-year in May, with total revenue rising by 44.97% [16] Group 13 - Jiacheng International signed a two-year air transport service contract with a well-known e-commerce platform, ensuring annual revenue of no less than 500 million yuan [18] Group 14 - Zhonggu Logistics' shareholders plan to reduce their holdings by up to 3% of the company's shares [20] - CITIC Guoan intends to reduce its holdings of Hubei Broadcasting shares by up to 11.37 million shares [20]

Core Viewpoint - *ST Hengli is under investigation by the China Securities Regulatory Commission (CSRC) for suspected false disclosures in its annual report and other financial documents, facing a delisting risk due to failure to timely disclose periodic reports [1][14]. Financial Performance - *ST Hengli's revenue from 2021 to 2023 showed a significant decline, with revenues of 3.46 billion, 2.46 billion, and 1.11 billion respectively, reflecting year-on-year changes of 13.19%, -28.86%, and -54.74% [2]. - The company's net profit attributable to shareholders for the same period was 0.02 billion, -0.13 billion, and -0.11 billion, with year-on-year changes of -42.99%, -870.88%, and 13.40% [2]. Audit and Reporting Issues - The company faced challenges in its 2023 annual report, initially forecasting revenue of 1.5 billion to 1.8 billion, later revised down to 1 billion to 1.2 billion, a reduction of 33.33% [3]. - The audit report from Yongtuo Accounting Firm raised concerns about the company's ability to continue as a going concern, leading to a risk warning for delisting [3]. - *ST Hengli's failure to disclose over half of its board's assurances regarding the accuracy of the 2024 annual report resulted in a delisting risk warning from the Shenzhen Stock Exchange [3]. Legal Actions and Controversies - Following the receipt of a delisting warning, *ST Hengli filed a lawsuit against its auditing firm, Xutai, claiming damages of 38.27 million due to delays in the audit report [1][6]. - The company appointed a new auditor, Tangtang, without following the required shareholder meeting procedures, raising compliance concerns [10]. Revenue Adjustment Attempts - On May 31, *ST Hengli attempted to adjust its 2023 revenue figures by hiring Tangtang to issue a new verification report, arguing that certain income should not have been deducted [7]. - The company had previously accepted the auditor's opinion on revenue deductions without objection, leading to questions about the legitimacy of its recent claims [8]. Regulatory Compliance Issues - *ST Hengli's disclosures regarding its financial adjustments were not made through the designated media, violating regulatory requirements [13]. - The company justified its internal announcement process by claiming that relevant personnel at the Shenzhen Stock Exchange failed to disclose information in a timely manner, which does not absolve it of compliance responsibilities [13].

Core Viewpoint - Dongmu Co., Ltd. (600114) received a warning letter from the Ningbo Securities Regulatory Bureau, indicating violations by the company and responsible individuals [1] Summary by Relevant Sections Regulatory Actions - The company failed to timely disclose the share acquisition clause in the equity transfer agreement with Shanghai Fuchi, which states that Shanghai Fuchi has not independently listed its shares within five years, with the disclosure only made on March 24, 2025 [1] - The Ningbo Securities Regulatory Bureau decided to issue a warning letter to the company and responsible individuals, including former Chairman and General Manager Zhu Zhirong and former Secretary of the Board Yan Fengmu, holding them primarily accountable for the violations [1] Compliance and Remediation - The company and related personnel have undertaken corrective actions, enhancing their understanding of laws and regulations, and improving the quality of information disclosure and operational compliance [1]

Core Viewpoint - Shenghui Intelligent Technology Co., Ltd. faced regulatory action from the Shandong Regulatory Bureau of the China Securities Regulatory Commission due to inaccurate disclosure in its 2024 performance forecast, leading to a warning letter and entry into the securities market integrity database [3][4]. Company Overview - Shenghui Technology was established on December 11, 2003, with a registered capital of 4.975 billion RMB. The company is headquartered in Laiyang, Shandong Province, and its main business includes electrical equipment, smart city services, new energy, and new materials [4]. - The current chairman is Li Zhaoqiang, and the company has 812 employees. The actual controller is also Li Zhaoqiang. The company has 23 subsidiaries, including several in the new energy sector [5]. Financial Performance - The company's revenue for 2022 to 2024 is projected to be 2.147 billion RMB, 2.002 billion RMB, and 1.455 billion RMB, reflecting year-on-year changes of -20.79%, -6.72%, and -27.32% respectively [5]. - The net profit attributable to shareholders for the same period is expected to be -981 million RMB, -1.696 billion RMB, and -120 million RMB, with year-on-year changes of -569.85%, -72.82%, and 92.93% respectively [5]. - The asset-liability ratios for the years 2022 to 2024 are 44.35%, 55.29%, and 52.89% [5]. Risk Assessment - The company has a total of 201 internal risks and 204 external risks, with 127 warning alerts currently active [6].

Core Viewpoint - The company received a warning letter from the Jiangsu Securities Regulatory Bureau due to improper revenue recognition in its digital marketing business, leading to inaccurate financial disclosures [3][4]. Financial Performance - The company's revenue for 2022, 2023, and 2024 was 1.738 billion, 1.482 billion, and 1.136 billion RMB, reflecting year-on-year growth rates of 49.61%, -15.58%, and -23.37% respectively [4]. - The net profit attributable to shareholders for the same years was 50.12 million, 26.39 million, and 30.46 million RMB, with year-on-year changes of -40.97%, -47.35%, and 15.44% respectively [4]. - The asset-liability ratios for 2022, 2023, and 2024 were 12.83%, 10.87%, and 18.09% respectively [4]. Corporate Governance - The company has acknowledged its accounting errors and has taken corrective actions, including a board meeting to approve adjustments to prior financial data [3]. - The chairman and general manager, Wang Kun, along with the financial director, Cao Jianxin, were held primarily responsible for the violations [3]. Company Overview - The company was established on September 14, 2012, with a registered capital of 80.3678 million RMB [3]. - It operates in mobile information services and digital marketing, with 243 employees and 21 subsidiaries [4].

Core Viewpoint - Zhejiang Heda Technology Co., Ltd. faced disciplinary action from the Shanghai Stock Exchange due to inaccurate financial disclosures, which significantly misled investors regarding the company's performance [3][17][19] Financial Performance Summary - The company initially forecasted a net profit attributable to shareholders of between 5 million to 7 million yuan for 2024, but later reports revealed a net loss of 563.61 million yuan [1][16] - The revised financial results showed a substantial decline in operating profit, with a reported loss of 1,754.83 million yuan and a total profit loss of 1,760.79 million yuan [2][16] - The company reported a significant drop in cash flow from operating activities, with a net cash flow of -1,133.40 million yuan compared to 3,679.48 million yuan in the previous year [6] Compliance and Regulatory Issues - The company violated multiple provisions of the Shanghai Stock Exchange's rules regarding timely and accurate information disclosure, leading to a lack of transparency that affected investor expectations [3][17][19] - The disciplinary action included a public reprimand for the company's executives, including the chairman, general manager, financial director, and board secretary, for failing to fulfill their responsibilities [4][19] Management Accountability - Key executives, including Chairman Guo Jun and General Manager Weng Xianhua, were identified as responsible for the company's failure to disclose accurate financial information [4][18] - The company is required to implement corrective measures and submit a report detailing these actions within one month of receiving the disciplinary notice [19][20]

Core Viewpoint - The investigation by the China Securities Regulatory Commission (CSRC) into Jiaying Pharmaceutical highlights severe governance issues within the company, exacerbated by a significant decline in revenue from its core products and ongoing management turmoil [2][3][15]. Governance and Management Issues - Jiaying Pharmaceutical is under investigation for information disclosure violations, which are seen as a culmination of long-standing governance deficiencies [3][15]. - The company has experienced a rapid turnover of key executives, including the resignation of the financial director and board secretary, raising concerns about internal governance stability [4][5]. - A lack of timely disclosure regarding related party transactions and internal control weaknesses has been identified as potential triggers for the investigation [3][5]. Financial Performance - Jiaying Pharmaceutical reported a revenue of 376.17 million yuan in 2024, a decrease of 29.46% year-on-year, marking two consecutive years of double-digit declines [6][7]. - The net profit attributable to shareholders fell to 20.61 million yuan, down 39.94% from the previous year, with a net profit margin dropping from 6.44% in 2023 to 5.48% in 2024 [6][7]. - The company's core products, particularly the Jieguzhili Pian/Capsule, saw a revenue decline of 41.05%, significantly impacting overall performance [9][10]. Market and Product Dynamics - The ongoing pressure from national traditional Chinese medicine procurement policies has led to a dual impact of declining prices and sales volumes for Jiaying Pharmaceutical's key products [9][10]. - The company’s revenue structure is imbalanced, with major products underperforming and insufficient growth from secondary products, leading to a "main force slowdown, new force insufficiency" scenario [9][10]. Research and Development Concerns - Jiaying Pharmaceutical's R&D expenditure decreased by 33.09% in 2024, raising concerns about its long-term competitiveness and innovation capabilities [14][15]. - The reduction in R&D personnel from 42 to 30 indicates a shrinking focus on innovation, which is critical in the increasingly competitive pharmaceutical industry [14][15]. Recent Developments - In the first quarter of 2025, Jiaying Pharmaceutical reported a revenue increase of 28.83% year-on-year, attributed to expanded sales channels, although this was not accompanied by improved cash flow [11][12]. - Despite a temporary recovery in performance, the ongoing decline in R&D investment poses risks to the company's future growth and sustainability [14][15].

Core Viewpoint - The company, Ruibeka, has faced regulatory warnings due to failure to disclose its 2024 annual performance forecast, resulting in a net loss of 118 million yuan, and has been warned twice in a month for various compliance issues [2][3]. Group 1: Regulatory Warnings and Compliance Issues - Ruibeka's chairman, general manager, board secretary, and financial director received warnings from the regulatory authority for not disclosing the annual performance forecast within the required timeframe [2][3]. - The company has been cited for multiple compliance failures, including undisclosed non-operating fund transactions with related parties and insufficient inventory impairment provisions [3]. - The regulatory authority has mandated corrective actions and issued warning letters to the responsible executives, which will be recorded in the securities market integrity archives [3]. Group 2: Financial Performance and Operational Challenges - In 2023, Ruibeka reported a revenue of 1.2 billion yuan, a year-on-year increase of 1.1%, but incurred a loss due to a 62% increase in marketing expenses aimed at promoting new cross-border e-commerce channels [2]. - The company’s net profit for 2023 was reported at 12.3 million yuan, highlighting a significant operational challenge in managing costs while expanding marketing efforts [2]. - The company had a beginning balance of 300 million yuan in non-operating fund occupation by its controlling shareholder, which has since been fully repaid by the end of the reporting period [4][5]. Group 3: Internal Control and Remedial Actions - Ruibeka has acknowledged internal control deficiencies related to the approval and disclosure processes for related party transactions, which have been addressed through self-examination and corrective measures [4][5]. - The company plans to enhance the awareness of securities laws and regulations among its board members and key personnel to prevent future compliance issues [5].

Group 1 - *ST Jinglan has been issued a "Notice of Case Filing" by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, marking a recurrence of such issues since July 2023 [2] - The company has previously faced penalties for multiple disclosure violations, including failure to disclose goodwill impairment in annual reports for 2021 and 2022, resulting in a fine of 3 million yuan [2] - The company has committed to improving internal governance and enhancing the quality of information disclosure to protect the interests of shareholders [2] Group 2 - *ST Jinglan's main business includes industrial and urban solid waste harmless disposal and soil environment remediation, but its performance has been declining [3] - Revenue has decreased from 738 million yuan in 2021 to 195 million yuan in 2022, and further down to 149 million yuan in 2023, a year-on-year decline of 23.69% [3] - Although revenue is projected to increase to 378 million yuan in 2024, the company is expected to incur a net loss of 110 million yuan, a year-on-year increase of 110.41% [3] Group 3 - In Q1 2025, *ST Jinglan reported revenue of 126 million yuan and a net loss of 12.95 million yuan [4] - The company attributed the Q1 loss to production stoppages during the Spring Festival, which significantly reduced profits due to depreciation, labor, and interest costs [4] - Annual maintenance costs also contributed to the reduced profits, leading to a pattern of low or negative profits in the first quarter of each year [4]